| Identification | Back Directory | [Name]
Nemonapride | [CAS]
93664-94-9 | [Synonyms]
Unii-Q88T5p3444
Nemonapride USP/EP/BP
(+-)-cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide
N-(2Rs,3rs)-(1-benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide
Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-((2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-, rel- | [Molecular Formula]
C21H26ClN3O2 | [MOL File]
93664-94-9.mol | [Molecular Weight]
387.903 |
| Hazard Information | Back Directory | [Description]
Nemonapride, also known as YM-09151-2 and Emilace, is a dopamine D2/D3/D4 receptor antagonist for the treatment of schizophrenia. | [Definition]
ChEBI: N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide is a benzamide obtained by formal condensation of the carboxy group of 5-chloro-2-methoxy-4-(methylamino)benzoic acid with the amino group of 1-benzyl-2-methylpyrrolidin-3-amine. It is a N-alkylpyrrolidine, a member of benzamides, a member of monochlorobenzenes, a secondary amino compound, a monomethoxybenzene, a substituted aniline and a secondary carboxamide. |
|
|